Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
Relevance. The vaccine against the SARS-Cov-2 coronavirus is considered as the most promising approach to curb (tame) a current pandemic and prevent new one. Three vaccines (AstraZeneca’s СhAdOx1 nCov-19, CanSino’s vaccine and Russia’s Sputnik V one) are in Phase III clinical trials and have the S p...
Saved in:
| Main Author: | E. P. Kharchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2020-11-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1080 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
by: Shengxue Luo, et al.
Published: (2021-01-01) -
Developing the next-generation of adenoviral vector vaccines
by: Alexander T. Sampson, et al.
Published: (2025-12-01) -
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
by: Jia-Wei Xu, et al.
Published: (2024-12-01) -
Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy
by: Gloria Aguilar, et al.
Published: (2025-12-01) -
An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic
by: A. N. Morozov, et al.
Published: (2022-12-01)